Clostridium difficile infections in HIV-positive patients.

Area of Science:

• Infectious Diseases
• Microbiology
• Immunology

Background:

• Clostridium difficile infections (CDI) pose a significant risk, particularly in immunocompromised populations.
• HIV-positive individuals may have altered susceptibility to infections like CDI.
• Understanding the prevalence and characteristics of CDI in HIV patients is crucial for clinical management.

Purpose of the Study:

• To investigate the prevalence of Clostridium difficile enterotoxin in HIV-positive patients.
• To compare the prevalence of C. difficile enterotoxin between HIV-positive and HIV-negative diarrheal patients.
• To characterize C. difficile isolates from both patient groups.

Main Methods:

• Enzyme immunoassay (EIA) was used to detect C. difficile enterotoxin in stool samples.
• Stool specimens were collected from 201 HIV-positive and 271 HIV-negative diarrheal patients.
• C. difficile culture, latex agglutination test, and pulsed-field gel electrophoresis (PFGE) were performed.

Main Results:

• C. difficile enterotoxin was detected in 58.8% of HIV-positive diarrheal patients and 36.5% of HIV-negative diarrheal patients.
• Enterotoxin was found in 12.6% of HIV-positive non-diarrheal patients.
• 13.6% of samples were culture-positive but toxin-negative; 6 PFGE patterns were identified among isolates.

Conclusions:

• HIV-positive patients exhibit a higher prevalence of C. difficile enterotoxin.
• Enterotoxin detection assays may miss some C. difficile infections, necessitating confirmatory testing.
• Further research into the specific virulence factors and host-pathogen interactions in HIV-associated CDI is warranted.